TENNILLE BLOCK: Open Payments
NPI 1275036311 · SMYRNA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,890 in 93 payments from 16 companies in 2025. Trend: 2023 $790 · 2024 $667 · 2025 $1,890
Food & beverage: $1,890
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $326 |
| GENZYME CORPORATION | 13 | $279 |
| ARS Pharmaceuticals Operations, Inc. | 13 | $270 |
| GlaxoSmithKline, LLC. | 19 | $236 |
| Regeneron Healthcare Solutions, Inc. | 6 | $137 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $129 |
| Novartis Pharmaceuticals Corporation | 6 | $111 |
| Grifols USA, LLC | 4 | $71 |
| Optinose US, Inc. | 3 | $59 |
| Genentech USA, Inc. | 2 | $53 |
Products named: DUPIXENT, NEFFY, FASENRA, NUCALA, CUVITRU, AIRSUPRA, TRELEGY ELLIPTA, Xembify.
Industry payments across TN — which companies pay providers there.
